Cirrus Therapeutics

Developer of therapies designed to extend ocular healthspan and restore vision

placeCambridge, Massachusetts, United States calendar_todayFounded 2021 language cirrustx.com

Innovation

1 patent family — focus: Chemistry & metallurgy; filing pace active. Cited 119 times.

YearFilings
20251

Social engagement

Social engagement: 2.2K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

3 investors on record; lead investors include Clavystbio.

Investor typeCountShare
Venture capital267%
Other / undisclosed133%

Recent activity

30 Jun 2026
Event
BIO International Convention 2026
16 Jun 2026
Recognition
2 Jun 2026
Leadership hire
Vice President of Translational Research
Coming soon